NEW YORK (NY, USA) May 24, 2011 - Exosome Diagnostics, a leading developer of biofluid based molecular diagnostic tests for use in personalised medicine, today announced the appointments of Bob Carter MD, PhD, Carlos Cordon-Cardo MD, PhD, Keith Flaherty MD, John Quackenbush, PhD; to its Scientific Advisory Board (SAB).
Dr. Cordon-Cardo is Vice Chairman of Pathology and Professor of Pathology and Urology at Columbia University in addition to being Associate Director of Infrastructure at the Herbert Irving Comprehensive Cancer Center.
Dr. Cordon-Cardo obtained his M.D. from the Autonomous University of Barcelona, Spain, in 1980, and his Ph.D. in Cell Biology and Genetics from Cornell University Medical College in 1985.
has pioneered the development and implementation of an oncologic molecular pathology discipline, and more recently participated in the creation of the "systems pathology" platform.
is internationally recognized for his
studies on experimental pathology and molecular oncology, including analyses of multidrug resistance and alterations of tumor suppressor genes in human cancer, mainly those deregulating cell cycle.